Published in FDA Law Weekly, December 16th, 2004
"This is great news for people with diabetes," said Bill Marshall, president, diabetes care, BD medical. "Coupled with the BD Ultra-Fine 33 gauge Lancets - the thinnest lancet on the market - this clearance by the FDA equating palm testing with fingertip testing for users of the BD Logic and Paradigm Link provides people a more convenient and comfortable 'best in class' approach...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.